Introduction List of Opinions

Opinions On Any Scientific Matter

List of Opinions

2009
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, on bisphosphonates and osteonecrosis of the jaw
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, on the use of Tamiflu and Relenza in specific populations
 
2008
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, on conventional antipsychotics
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, on Antidepressants
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, on the potential risks of carcinogens, mutagens and substances toxic to reproduction when these substances are used as excipients of medicinal products for human use
CHMP opinion pursuant to Article 5(3) of Regulation(EC) No 726/2004, for Heparins
CHMP assessment report for medicinal products containing or derived from Heparin under Article 5(3) of Regulation (EC) No 726/2004
 
2007
CVMP/CHMP opinion on presence of the antibiotic resistance marker gene nptII in GM plants for food and feed uses
 
2006
CHMP opinion on adequacy of guidance on the elderly regarding medicinal products for human use
CHMP review on non-selective non-steroidal anti-inflammatory drugs (NSAIDs) (24 October 2006)